Skip to main content

Search form

Search

About the Department
Divisions
Faculty
- Distinguished Faculty
- Faculty Development
Patient Care
- Referrals
- In the Community
Research
Education and Training
MedicineNews

About the Department
Divisions
Faculty
- Distinguished Faculty
- Faculty Development
Patient Care
- Referrals
- In the Community
Research
Education and Training
MedicineNews

Home
Divisions
Hematologic Malignancies and Cellular Therapy
Research
Clinical Research

Hematologic Malignancies and Cellular Therapy

Clinical Research

Learn About Our Clinical Trials

BMT and Cellular Therapies
Leukemia and Multiple Myeloma
Lymphomas - Non-Hodgkins Lymphoma and Hodgkins Lymphoma

About
Faculty
Patient Care
Education and Training
Research
Division Events
Division News

Recent Articles

Faculty promotions from January through June 2018

Divisions select faculty recipients for 2018 Excellence in Education Awards

Webb + LeBlanc present at Duke PC grand rounds

Strong Start award gives Phuong Doan the chance to ask high-risk, high-reward questions

Duke research on patient-related outcomes in cancer care is honored by Springer Nature journals

Recent publications by our faculty

Palliative Performance Scale Score at 1 Week After Palliative Care Unit Admission is More Useful for Survival Prediction in Patients With Advanced Cancer in South Korea.

The American Journal of Hospice & Palliative Care

A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33 positive AML.

Blood

Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-Only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry.

Clinical Therapeutics

View all our publications

Quick Links

Diversity
Careers
Giving
About Duke and Durham

Twitter Instagram RSS

medschool.duke.edu
duke.edu
dukehealth.org

Copyright 2004-2018 Duke University and Duke University Health System, All rights reserved